AstraZeneca doubles down on cardiometabolic future as Farxiga patent cliff looms

Feb 10, 2026

AstraZeneca PLC

AstraZeneca's Robust Q3 2025 Performance Driven by Strong Product Demand

Nov 6, 2025

AstraZeneca PLC

AstraZeneca's Strong Growth Continues with Robust Half-Year Earnings

Jul 29, 2025

AstraZeneca PLC

AstraZeneca's Q1 2025 Earnings Paints a Promising Future

Apr 29, 2025

AstraZeneca PLC

AstraZeneca Surges with Robust 2024 Performance and Optimistic Projections for 2025

Feb 6, 2025

AstraZeneca PLC